China Monoclonal Antibody Market Is Expected to Exceed CNY 10 Billion by 2017 SBWire (press release) Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avastin, Herceptin, Rituximab, etc. In 2012, its sales value of monoclonal antibody products reached USD ... |
